A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

Astellas

Status and phase: Completed; Phase 3

Conditions: Psoriasis

Treatments: Drug: Tacrolimus Cream

Study type: Interventional

Funder types: Industry

Identifiers

NCT00293917

04-0-207

Details and patient eligibility

About

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Full description

A long-term, open label, non-comparative, multi-center study to evaluate the safety of tacrolimus cream-B 0.1% in treating the signs and symptoms of psoriasis.

Enrollment: 658 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of plaque psoriasis

Exclusion criteria

• Skin disorder other than plaque psoriasis in the areas to be treated.
• Disease on only scalp

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)